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Abstract
Background: Cimetidine, an antagonist of histamine type II receptors, has shown protective effects against γ-rays
or neutrons. However, there have been no reports on the effects of cimetidine against neutrons combined with
γ-rays. This study was carried out to evaluate the protective effects of cimetidine on rats exposed to long-term,
low-dose-rate neutron and γ-ray combined irradiation (n-γ LDR).
Methods: Fifty male Sprague-Dawley (SD) rats were randomly divided into 5 groups: the normal control group,
radiation model group, 20 mg/(kg · d) cimetidine group, 80 mg/(kg · d) cimetidine group and 160 mg/(kg · d)
cimetidine group (10 rats per group). Except for the normal control group, 40 rats were simultaneously exposed to
fission neutrons (252Cf, 0.085 mGy/h) for 22 h every day and γ-rays (60Co, 0.097 Gy/h) for 1.03 h once every three
days, and the cimetidine groups were administered intragastrically with cimetidine at doses of 20, 80 and 160
mg/kg each day. Peripheral blood WBC of the rats was counted the day following exposure to γ-rays. The rats were
anesthetized and sacrificed on the day following exposure to 252Cf for 28 days. The spleen, thymus, testicle, liver
and intestinal tract indexes were evaluated. The DNA content of bone marrow cells and concanavalin A (ConA)-
induced lymphocyte proliferation were measured. The frequency of micronuclei in polychromatic erythrocytes
(fMNPCEs), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px) in the serum
and liver tissues were detected.
Results: The peripheral blood WBC in the cimetidine groups was increased significantly on the 8th day and the
26th day compared with those in the radiation model group. The spleen, thymus and testicle indexes of the
cimetidine groups were higher than those of the radiation model group. The DNA content of bone marrow cells
and lymphocyte proliferation in the cimetidine groups were increased significantly, and fMNPCE was reduced
1.41-1.77 fold in cimetidine treated groups. The activities of SOD and GSH-Px in the cimetidine groups were
increased significantly, and the content of MDA in the cimetidine groups was decreased significantly.
Conclusions: The results suggested that cimetidine alleviated damage induced by long-term, low-dose-rate
neutron and γ combined irradiation via antioxidation and immunomodulation. Cimetidine might be useful as a
potent radioprotector for radiotherapy patients as well as for occupational exposure workers.
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Background
Most of the data on radioprotection have been derived
from studies using low linear energy transfer (LET) X-
and γ-radiation. Exposure to high LET radiation can also
be expected during long-term space flights, occupational
exposure in nuclear plants, and tumor radiotherapy. It
was demonstrated that neutrons and other high LET radi-
ation induce more severe biological effects than low LET
radiation for the same absorbed dose [1, 2]. Thus, protec-
tion against high LET radiation should be given more
attention. It was observed that cysteine with a dose reduc-
tion factor (DRF) of 1.7 for γ-rays was shown to have a
DRF of only 1.1 in mice against neutrons [3]. From the
discovery of the radio-protective effect of cysteine, in-
creasingly more compounds have been used in an attempt
to provide partial protection against radiation injury.
However, thus far, sulfhydryl compounds remain the main
radioprotectors, such as mercapto-ethylamine (MEA),
aminethylisothiouronium (AET) and amifostine (WR-
2721) [4]. However, the side effects of these radioprotec-
tors have limited their clinical application [5]. Therefore,
the development of new drugs that are less toxic and ef-
fective even for high LET exposure is desired for the pro-
tection of medical and occupational exposure to radiation.
Cimetidine, an antagonist of histamine type II recep-
tors that is usually used for peptic ulcer treatment, has
shown protective effects against radiation, not only high
LET neutrons but also low LET γ or X-rays. Cimetidine
was shown to be effective against the clastogenic effects
of γ-rays [6, 7] and X-rays [8] in vitro. It was also dem-
onstrated to be protective against γ-rays and neutrons in
vivo [7, 9–12]. Cimetidine was shown to inhibit the
activity of suppressor T cells [13] and was used in radio-
protection to help the recovery of the lymphohemato-
poietic system effectively [10]. H2-receptor antagonists
have potential oxygen-radical-scavenging properties. It
was reported that cimetidine could scavenge OH with a
very high rate constant [14]. Mice treated with cimeti-
dine could tolerate biomembrane damage provoked by
sublethal γ-radiation. This supports the hypothesis that
cimetidine may afford efficient protection against ioniz-
ing radiation or diseases that are characterized by in vivo
free radical-mediated oxidative stress mechanisms [15].
It was shown that cimetidine, ranitidine, and famotidine
produced a DRF of 1.5 to 2 against γ-ray-induced micro-
nuclei in mouse bone marrow erythrocytes [9, 16]. Ci-
metidine, compared with famotidine, was found to be
more protective against mortality induced by radiation
in mice [12].
In this study, SD rats were exposed to long-term, low-
dose-rate neutron and γ combined irradiation (n-γ LDR)
with or without cimetidine supplementation, and the




Cimetidine was purchased from Tianjin Smith Kline
&French Laboratories Ltd (Tianjin, China). Superoxide
dismutase (SOD), malondialdehyde (MDA), and gluta-
thione peroxidase (GSH-Px) kits were purchased from
the Nanjing Jiancheng Bioengineering Institute.
Animals and treatments
Five-week-old male SD rats were purchased from Sino-
British SIPPR/BK Lab. Animal Co. Ltd. The rats were
maintained under conditions of standard lighting
(12:12 h light–dark cycle), temperature (20–22 °C) with
freely available food and water. The animals were ran-
domly divided into 5 groups (n = 10): normal control
group, radiation model group, 20 mg/(kg · d) cimetidine
group, 80 mg/(kg · d) cimetidine group and 160 mg/
(kg.d) cimetidine group. Cimetidine was administered by
intragastric infusion with the volume of 10 ml/kg each
day. The Institutional Animal Care and Use Committees
of the Naval Medical Research Institute approved all
procedures for animal care and treatment.
Animal irradiation
From the first day of cimetidine administration, animals,
except those in the normal control group, were whole-
body exposed to fission neutrons (252Cf, 0.085 mGy/h,
the Radiation Center of the Naval Medical Research In-
stitute) 22 h every day for 28 days, and γ-rays (60Co,
0.097 Gy/h, the Radiation Center of the Naval Medical
Research Institute) 1.03 h once every three days. The
cumulative doses were 52.36 mGy of neutron and 1.0 Gy
of γ-rays. The radiation method and doses are shown in
Table 1.
Peripheral blood white blood cell (WBC) count
Whole blood was collected from the rat tail into EDTA-
coated tubes on the 3rd day before radiation and on the
8th, 17th and 26th days after radiation, and the absorbed
doses of neutrons and γ-rays on these days are shown in
Table 1. Peripheral blood WBC counts were obtained
using a veterinary hematology analyzer (Nihon Kohden
Corporation, Japan) according to the operator’s manual.
Table 1 Accumulated dose of n-γ LDR on the day of vein blood
collection
Radiation 8th day 17th day 26th day 29th day
Neutron (mGy) 13.09 29.92 46.75 52.36
γ-rays (Gy) 0.3 0.6 0.9 1.0
The 8th, 17th, 26th and 29th day indicates the time points of vein blood
collection; at these time points, the rats were actually exposed to n-γ LDR for
7, 16, 25 and 28 days
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Organ weight index detection
Animals were anesthetized and sacrificed on the next
day after exposure to 252Cf for 28 days. The spleen, thy-
mus, testicle, liver, and intestinal tract were separated,
and organ indexes were determined using the following
equation: Organ index = organ weight/body weight.
Bone marrow DNA content detection
The next day after finished all the irradiation, the right
femur of each animal was removed and cleaned of ad-
herent tissues. The bone marrow was flushed into 5 ml
of a 5-mmol/L CaCl2 solution and was incubated at 4 °C
for 30 min. Cell suspensions were centrifuged at 2,500 r/
min for 15 min, and the pellet was resuspended in 5 ml
0.2 mol/L HClO4. The suspension was incubated at
90 °C for 15 min and was filtered through a 0.22-μm
membrane. The absorbance at 260 nm was detected
using a 759 UV spectrophotometer (Shanghai APL in-
strument Co., Ltd.).
Detection of SOD, MDA, and GSH-Px in serum and hepatic
tissue
The next day after finished all the irradiation, blood was
collected from the inferior vena cava into clean centri-
fuge tubes. Serum was prepared by centrifugation at
3,000 × g for 15 min. Next, 100 mg of hepatic tissue
filled with 0.9 ml of normal saline was homogenized
with a pulping machine, and the supernatant was pre-
pared by centrifugation at 3,000 × g for 15 min. SOD,
MDA, and GSH-Px in serum and hepatic tissue superna-
tants were determined using detecting kits from Nanjing
Jiancheng Bioengineering Institute according to the
manufacturer’s instructions.
Concanavalin A (ConA)-induced splenocyte proliferation
assay
The next day after finished all the irradiation, splenic
lymphocytes were prepared as previously described [17].
One milliliter of spleen cell suspension (3 × 106 cells/ml)
was added into 24-well plates and cultured with 75 μl of
100 μg/ml ConA solution. The plates were incubated at
37 °C with 5% CO2 for 68 h, and then 0.7 ml of super-
natant in each well was discarded and 0.7 ml of RPMI
1640 medium was added. Next, 50 μl of fresh prepared
MTT solution (5 mg/ml, dissolved in PBS, pH 7.2) was
added into each well and incubated under the same con-
ditions for 4 h. Finally, 1 ml of acid-isopropanol solution
(1 mol/L HCl/isopropanol was 4/96(v/v)) was added into
each well and mixed thoroughly until the purple crystals
were fully dissolved. The absorbance at 570 nm was
determined.
Detection of the frequency of micronuclei in
polychromatic erythrocyte (fMNPCE) in the bone marrow
The next day after finished all the irradiation, bone mar-
row samples were collected from the left femur of each
animal. The bone marrow was flushed into 1.5-ml tube
used by 400 μl of fetal bovine serum (FBS), and then
200 μl of suspension was fixed by adding 5.0 ml of 1%
glutaraldehyde solution containing 30 μl/ml SDS and
0.05 mol/L Sorensen. The fixed cells were incubated for
5 min and then were centrifuged at 300 × g for 5 min.
The cell pellets were suspended in 1.0 ml of acridine or-
ange staining solution and staining for 30 min at 37 °C.
The stained cells were analyzed using the Accuri C6 flow
cytometer (BD Biosciences, NJ, USA). At least 10,000
cells/sample were collected, and the fMNPCE was
analyzed.
Statistical analysis
Statistical analysis was performed by one-way analysis of
variance (AVOVA) followed by LSD t-test using SPSS
(version 16.0). All of the values were expressed as mean
as the means ± standard deviation (SD). P values <0.05
were considered to be statistically significant.
Results
Protection effect of cimetidine on peripheral blood WBC
of irradiated rats
The results are shown in Table 2. Peripheral blood WBC
in all groups was not significantly different on the 3rd
day before radiation (P > 0.05). WBC in the irradiation
groups was decreased significantly on the 8th, 17th and
26th days, respectively (P < 0.01). On the 8th day,
WBC in the cimetidine groups was increased signifi-
cantly compared with that in the radiation model
Table 2 Effect of cimetidine on peripheral blood WBC counts in n-γ LDR rats (×109/L, x ± s, n = 10)
Group 3rd day before IR 8th day 17th day 26th day
Normal control group 10.9 ± 1.6 11.6 ± 1.2 10.7 ± 1.2 10.0 ± 2.6
Radiation model group 10.8 ± 2.2 7.7 ± 1.0(1) 8.2 ± 2.3(1) 6.3 ± 0.7(1)
20 mg/(kg · d) cimetidine group 10.7 ± 1.5 11.3 ± 2.1(3) 8.6 ± 1.3(1) 7.2 ± 1.2(1)(2)(4)
80 mg/(kg · d) cimetidine group 10.6 ± 1.7 9.0 ± 1.6(1)(2) 7.9 ± 1.1(1) 7.2 ± 1.0(1)(2)(4)
160 mg/(kg · d) cimetidine group 10.5 ± 1.5 9.0 ± 1.9(1) 8.4 ± 1.2(1) 5.8 ± 1.2(1)
(1)P < 0.01 compared with the normal control group; (2)P < 0.05, (3)P < 0.01 compared with the radiation model group; (4)P < 0.05 compared with the 160 mg/(kg · d)
cimetidine group. The 8th, 17th and 26th day were the days that the rats were exposed to n-γ LDR for 7, 16 and 25 days, respectively
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group (P < 0.01 in the 20 mg/(kg · d) group, P < 0.05 in
the 80 mg/(kg · d) group). On the 26th day, WBC in
the 20 mg/(kg · d) and 80 mg/(kg · d) cimetidine
groups was increased significantly compared with that
in the radiation model group (P < 0.05). These results
suggested that cimetidine has a promotion effect on
peripheral blood WBC of n-γ LDR rats.
Protection effect of cimetidine on the organ indexes of
irradiated rats
The results are shown in Table 3. The spleen indexes,
thymus indexes, and testicle indexes of the radiation
model group were decreased significantly compared with
those of the normal control group (P < 0.05 or P < 0.01),
and the liver indexes and intestinal tract indexes showed
no significant difference (P > 0.05). The spleen indexes of
the cimetidine groups were increased compared with
those of the radiation model group (P < 0.01 in the
20 mg/(kg · d) cimetidine group and P < 0.05 in the
160 mg/(kg · d) cimetidine group). The thymus indexes
of the 20 mg/(kg · d) cimetidine group were increased
compared with those of the radiation model group (P <
0.05). The testicle indexes of the 160 mg/(kg · d) cimeti-
dine group were increased compared with those of the
radiation model group (P < 0.05). The liver indexes and
intestinal tract indexes in all groups showed no signifi-
cant difference (P > 0.05). These results suggested that
n-γ LDR induced the damage effects on the spleen, thy-
mus and testicle, and cimetidine alleviated the damage
effects of the three organs in irradiated rats.
Effect of cimetidine on the DNA content of bone marrow
cells
The results are shown in Fig. 1. The DNA content of
bone marrow cells in the radiation model group was de-
creased significantly compared with that in the normal
control group (P < 0.01), and the DNA content in the ci-
metidine groups was increased compared with that in
the radiation model group (P < 0.01 in the 20 mg/(kg · d)
cimetidine group and P < 0.05 in the 80 mg/(kg · d) ci-
metidine group). These results suggested that bone mar-
row cells are damaged by n-γ LDR, and cimetidine has a
protective effect on the DNA of bone marrow cells in ir-
radiated rats.
Effect of cimetidine on ConA-induced splenocyte
proliferation
Figure 2 shows that ConA-induced splenocyte prolifera-
tion in the radiation model group was decreased signifi-
cantly compared with that in the normal control group
(P < 0.01), while in the 20 mg/(kg · d) or 80 mg/(kg · d)
cimetidine group was increased significantly compared
with that in the radiation model group (P < 0.05). The
results suggested that n-γ LDR have an injured effect on
the splenocytes of the irradiated rats, and cimetidine
ameliorated the damage, thus improving the splenocyte
proliferation in irradiated rats.
Effect of cimetidine on SOD, GSH-Px and MDA in serum
and hepatic tissue
Table 4 shows that the SOD activity in serum and hep-
atic tissue of the radiation model group was decreased
significantly compared with that of the normal control
group (P < 0.01), and the SOD activity in the 20 mg/
(kg · d) and 160 mg/(kg · d) cimetidine group of serum
and in the 20 mg/(kg · d) cimetidine group of hepatic
tissue were increased significantly compared with that
in the radiation model group (P < 0.05 or P < 0.01).
Table 5 shows that the GSH-Px activity in the serum of
the radiation model group was decreased significantly
Table 3 Effect of cimetidine on the organ indexes of n-γ LDR rats (mg/g, x ± s, n = 10)
Group Spleen index Thymus index Testicle index Liver index Intestinal tract index
Normal control group 2.16 ± 0.21 1.75 ± 0.14 8.20 ± 0.83 33.75 ± 4.01 0.38 ± 0.03
Radiation model group 1.74 ± 0.22(2) 1.41 ± 0.26(1) 7.44 ± 0.46(1) 32.81 ± 1.63 0.37 ± 0.03
20 mg/(kg · d) cimetidine group 2.02 ± 0.23(4) 1.69 ± 0.29(3) 7.88 ± 0.58 32.03 ± 1.24 0.38 ± 0.02
80 mg/(kg · d) cimetidine group 1.89 ± 0.21(1) 1.64 ± 0.31 7.60 ± 0.61 31.63 ± 2.15 0.38 ± 0.02
160 mg/(kg · d) cimetidine group 1.91 ± 0.14(2)(3) 1.63 ± 0.29 7.94 ± 0.49(3) 34.34 ± 3.25 0.39 ± 0.03
(1)P < 0.05, (2)P < 0.01 compared with the normal control group; (3)P < 0.05, (4)P < 0.01 compared with the radiation model group
Fig. 1 Effect of cimetidine on the DNA content of bone marrow cells
in irradiated rats. 1. Normal control group; 2. Radiation model group; 3.
20 mg/(kg · d) cimetidine group; 4. 80 mg/(kg · d) cimetidine group; 5.
160 mg/(kg · d) cimetidine group. (1) P < 0.01 compared with the
normal control group; (2) P < 0.01, (3) P < 0.05 compared with the
radiation model group
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compared with that of the normal control group (P <
0.05), and the GSH-Px activity in serum of the 20 mg/
(kg · d) and 80 mg/(kg · d) cimetidine group was in-
creased significantly compared with that of the radi-
ation model group (P < 0.05). The GSH-Px activity in
hepatic tissue showed no significant difference of all
groups (P > 0.05). These results suggested that n-γ LDR
decreased the antioxidation activities of rats, and ci-
metidine had the effect of stimulating the activities of
antioxidation in n-γ LDR rats. Table 6 shows that the
MDA in serum and hepatic tissue of the radiation
model group was increased significantly compared with
that of the normal control group (P < 0.05 or P < 0.01).
The content of MDA in the 20 mg/(kg · d) and 160 mg/
(kg · d) cimetidine group in serum and in all cimetidine
groups in hepatic tissue was decreased remarkably com-
pared with that in the radiation model group (P < 0.05 or
P < 0.01). These results suggested that cimetidine had the
effect of stimulating serum and hepatic tissue MDA elim-
ination in n-γ LDR rats.
Effect of cimetidine on the fMNPCE in rat bone marrow
erythrocytes
The results are shown in Fig. 3 and Table 7. The
fMNPCE in the radiation group was increased signifi-
cantly compared with that in the normal control group
(P < 0.01), and the fMNPCE values in the three
cimetidine-treated groups were decreased significantly
compared with that in the radiation model group (P <
0.01). The DRF values of MN in the 20 mg/(kg · d),
80 mg/(kg · d) and 160 mg/(kg · d) cimetidine group were
1.41, 1.77 and 1.59, respectively. These results suggested
that cimetidine reduced the number of micronuclei in
bone marrow polychromatic erythrocytes of irradiated
rats, and protected against DNA damage induced by
radiation.
Discussion
Cimetidine can protect cells against the clastogenic ef-
fects of γ-rays or low-dose fast neutrons [6–9, 11]. How-
ever, there have been no reports on the effects of low-
dose-neutron combined γ-rays. In our study, the rats
were treated with whole-body n-γ LDR and administered
cimetidine at 20, 80 and 160 mg/(kg · d) by intragastric
infusion. The results showed that the fMNPCE of all
cimetidine-treated rats was reduced remarkably, with a
DRF of 1.41, 1.77 and 1.59, respectively. This suggested
that cimetidine can protect bone marrow polychromatic
erythrocytes against the clastogenic effects of n-γ LDR.
Fig. 2 Effect of cimetidine on ConA-induced splenocyte proliferation in
rats. 1. Normal control group; 2. Radiation model group; 3. 20 mg/(kg · d)
cimetidine group; 4. 80 mg/(kg · d) cimetidine group; 5. 160 mg/(kg · d)
cimetidine group. (1) P< 0.05, (2) P< 0.01 compared with the normal
control group; (3) P< 0.05 compared with the radiation model group
Table 4 Effect of cimetidine on SOD activity in serum and
hepatic tissues of n-γ LDR rats (x ± s, n = 10)
Group SOD in
serum (U/ml)
SOD in hepatic tissue
(U/mg protein)
Normal control group 20.22 ± 0.94 174.01 ± 20.84
Radiation model group 15.04 ± 1.60(2) 142.99 ± 4.03(2)
20 mg/(kg · d) cimetidine group 19.75 ± 5.39(4) 184.25 ± 7.59(4)
80 mg/(kg · d) cimetidine group 16.26 ± 3.60(1) 137.87 ± 26.99(2)(5)
160 mg/(kg · d) cimetidine group 17.47 ± 2.13(2)(3) 141.59 ± 11.04(2)(5)
(1)P < 0.05, (2)P < 0.01 compared with the normal control group; (3)P < 0.05,
(4)P < 0.01 compared with the radiation model group; (5)P < 0.05 compared
with the 20 mg/(kg · d) cimetidine group
Table 5 Effect of cimetidine on GSH-Px activity in serum and





Normal control group 1533.07 ± 222.34 230.67 ± 37.99
Radiation model group 1307.20 ± 178.43(1) 215.73 ± 21.05
20 mg/(kg · d) cimetidine group 1455.85 ± 103.16(2) 208.6 ± 12.90
80 mg/(kg · d) cimetidine group 1466.47 ± 173.53(2) 222.94 ± 29.92
160 mg/(kg · d) cimetidine
group
1423.29 ± 191.34 210.05 ± 32.30
(1)P < 0.05 compared with the normal control group; (2)P < 0.05 compared with
the radiation model group
Table 6 Effect of cimetidine on MDA in serum and hepatic
tissues of n-γ LDR rats (x ± s, n = 10)
Group MDA in serum
(nmol/ml)
MDA in hepatic tissue
(nmol/mg protein)
Normal control group 3.67 ± 0.431 4.18 ± 0.60
Radiation model group 4.02 ± 0.37(2) 4.89 ± 0.28(1)
20 mg/(kg · d) cimetidine group 3.70 ± 0.36(3) 4.34 ± 0.29(4)
80 mg/(kg · d) cimetidine group 3.83 ± 0.40 4.35 ± 0.53(3)
160 mg/(kg · d) cimetidine group 3.50 ± 0.38(4) 4.27 ± 0.30(4)
(1)P < 0.05, (2)P < 0.01compared with the normal control group; (3)P < 0.05,
(4)P < 0.01 compared with the radiation model group
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Ionizing radiation (IR) injury has been attributed to re-
active oxygen species (ROS)-mediated lipid peroxidation,
which can be estimated by measuring the concentration
of MDA. In the present study, cimetidine treatment rats
showed significantly reduced MDA levels in the serum
and liver, suggesting that cimetidine may diminish n-γ
LDR injury by decreasing ROS levels and reducing oxi-
dative damage.
Biological systems protect themselves against the dam-
aging effects of activated species by several means, in-
cluding free radical scavengers and enzymes such as
SOD and the GSH-Px system. It was reported that anti-
oxidants could reduce IR injury. H2-receptor antagonists
are scavengers of hydroxyl radicals with a very high rate
constant [8, 18]. They can stimulate SOD activity and
decrease the MDA concentration in the blood of patients
with peptic ulcer disease [19]. Mice treated with cimetidine
could tolerate biomembrane damage provoked by sublethal
γ-radiation [15]. The results in this study showed that SOD
and GSH-Px activities in the serum were decreased signifi-
cantly in n-γ LDR rats. The activity of SOD and GSH-Px
was increased by treatment with cimetidine. Treatment
with cimetidine possibly inhibited the accumulation of n-γ
LDR-induced free radicals, decreased the oxidative stress
and protected the antioxidant enzymes of rats as revealed
by the enhanced activities of SOD and GSH-Px in this
study. The results supported the hypothesis that cimetidine
might afford an efficient protection against IR or diseases
that were characterized by in vivo free radical-mediated
oxidative stress mechanisms [15].
Radiation-induced lymphohematopoietic syndrome is
characterized by a depression in the peripheral blood
levels of white and red blood cells and platelets, as well
as the loss of weight and decrease in the size of lymph-
atic tissues such as the spleen and thymus gland. In this
study, cimetidine was shown to have an effect of increas-
ing the number of WBC and DNA content of bone mar-
row cells. These results suggested that cimetidine may
play an important role in protecting the hematopoietic
system against n-γ LDR in vivo. This study also showed
that the spleen indexes, thymus indexes and splenocyte
proliferation of cimetidine-treated rats were increased
significantly. It also suggested that cimetidine can im-
prove the immune function of irradiated rats. Recent
studies have shown that cimetidine could modulate im-
mune responses. Cimetidine might act as a non-specific
stimulant of cell-mediated immunity and as an immuno-
modulator [20], and enhances antigen-specific IgE and
Fig. 3 FACS of rats on the frequencies of micronucleated polychromatic erythrocytes. a Normal control group; b Radiation model group;
c 20 mg/(kg · d) cimetidine group; d 80 mg/(kg · d) cimetidine group; e 160 mg/(kg · d) cimetidine group
Table 7 Effect of cimetidine on the fMNPCE in bone marrow
erythrocytes of n-γ LDR rats (x ± s, n = 10)
Group fMNPCE (%) DRF
Normal control group 0.150 ± 0.0216 —
Radiation model group 0.410 ± 0.0267(1) —
20 mg/(kg · d) cimetidine 0.290 ± 0.0213(1)(2) 1.41
80 mg/(kg · d) cimetidine 0.231 ± 0.0325(1)(2) 1.77
160 mg/(kg · d) cimetidine 0.258 ± 0.0268(1)(2) 1.59
(1)P < 0.01 compared with the normal control group; (2)P < 0.01 compared with
the radiation model group; “—”. No data
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Th2 cytokine production [21]. Cimetidine augments
Th1/Th2 dual polarized immune responses to recombin-
ant HBV antigens [22]. It has also been revealed that a
group of T cells with histamine receptors might have a
suppressive effect. Therefore, an antagonist of histamine
type II receptors might play a role in the immune system
and inhibit the function of suppressor T cells, mainly by
increasing the CD4+ cells of peripheral blood T lympho-
cytes [13, 23]. The administration of cimetidine prior to
irradiation leads to the inhibition of T suppressor cells
and an increase in the proliferation of CD4+ lympho-
cytes, causing the production of glutathione reductase
and catalase enzymes, which prevent DNA damage and
eventually reduce the clastogenic effect of radiation
[13, 24]. Thus, cimetidine might, via the regulation T
lymphocytes, protect rats against immune and oxida-
tive damage by n-γ LDR. These results suggested that
cimetidine may be a useful candidate radioprotector
for low-dose occupational radiation.
Conclusion
The effect of cimetidine on rats exposed to long-term n-γ
LDR was evaluated in this study. The results showed that
cimetidine increased the peripheral blood WBC, spleen,
thymus and testicle indexes, DNA content of marrow
cells, lymphocyte proliferation, and activities of SOD and
GSH-Px in n-γ LDR rats significantly but reduced the fre-
quency of micronuclei in polychromatic erythrocytes
(1.41–1.77 fold) and effectively decreased the content of
MDA in n-γ LDR rats. The results suggested that cimeti-
dine can alleviate damage induced by n-γ LDR via antioxi-
dation and immunomodulation. Cimetidine might be
useful as a potent radioprotector for radiotherapy patients
as well as occupational exposure workers.
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